NASDAQ · Medical - Diagnostics & Research

Sera Prognostics, Inc. (SERA) Stock

$2.04 +0.99% NASDAQ: SERA Healthcare

Valuation

MetricValue
Price$2.04
Market Cap$77.91M
P/E Ratio-3.12
P/B Ratio1.78
P/S Ratio1140.27
EPS (TTM)$-0.67
52-Week High$3.95
52-Week Low$1.56
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-46.71%
ROA-38.31%
ROCE-59.79%
Gross Margin-1.91%
Operating Margin-642.35%
Net Margin-563.86%
Debt/Equity0.05
Current Ratio1.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-35.0M$-46.0M$-40.0M$-37.0M$-37.0M
Net Profit$-35.0M$-44.0M$-36.0M$-33.0M$-32.0M
EPS$-1.18$-1.43$-1.16$-0.99$-0.67
Op Margin-43164.6%-17034.3%-13013.4%-47577.9%-45066.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$147.0M$116.0M$95.0M$73.0M$102.0M
Total Liabilities$8.0M$17.0M$25.0M$25.0M$27.0M
Cash$59.0M$30.0M$4.0M$4.0M$4.0M
Borrowings$0$3.0M$2.0M$1.0M$2.0M

Latest News

PRIME SUBGROUP ANALYSIS DEMONSTRATES 22% REDUCTION IN NICU ADMISSIONS IN FIRST-TIME PREGNANCIES USING PreTRM® Test-GUIDED CARE PR Newswire · Jul 9, 2026 SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF MARK CAPONE TO ITS BOARD OF DIRECTORS PR Newswire · Jun 30, 2026 SERA PROGNOSTICS COLLABORATES ON ARPA-H AWARD TO ADVANCE POINT-OF-CARE DIAGNOSTIC FOR SAFER BIRTH PR Newswire · Jun 24, 2026 SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY PR Newswire · Jun 23, 2026 All You Need to Know About Sera Prognostics (SERA) Rating Upgrade to Buy Zacks · Jun 19, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-32.0M$-35.0M$-27.0M$-14.0M$-26.0M
Investing Cash Flow$-84.0M$5.0M$0$11.0M$-29.0M
Financing Cash Flow$2.0M$0$1.0M$3.0M$0
Net Cash Flow$45.0M$-29.0M$-26.0M$0$0
Free Cash Flow$-33.0M$-35.0M$-27.0M$-15.0M$-26.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.13
EV / EBITDA-2.42
FCF Yield-35.26%
Quick Ratio1.98
Interest Coverage-5328.29
Return 1Y-20.00%
Return 3Y-33.54%
Return 5Y-80.36%

Ownership

Insiders Held11.89%
Institutions Held51.57%
Institutions Float Held58.53%
Institutional HolderSharesReport Date
Baker Bros. Advisors, LP5,498,1702026-03-31
Whetstone Capital Advisors, LLC3,306,8892026-03-31
Aberdeen Group plc2,550,7752026-03-31
Vivo Capital, LLC1,650,4402026-03-31
Vanguard Capital Management LLC1,204,1152026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APYXApyx Medical Corporation $2.59 +9.75% -12.68 $109.07M 0.00%
ATOSAtossa Therapeutics, Inc. $2.44 +0.83% -0.54 $24.34M 0.00%
CGTXCognition Therapeutics, Inc. $0.88 -2.04% -4.82 $78.48M 0.00%
HURATuHURA Biosciences, Inc. $1.96 +1.55% -3.46 $124.82M 0.00%
LUCDLucid Diagnostics Inc. $0.64 -1.86% -1.35 $121.71M 0.00%

About Sera Prognostics, Inc.

Sera Prognostics, Inc. is led by CEO Zhenya Lindgardt, employs 63 people, headquartered in US, publicly traded since 2021.

Sera Prognostics, Inc. (SERA) stock trades at $2.04 with a market capitalization of $77.91M. The stock is valued at a price-to-earnings (P/E) ratio of -3.12, price-to-book of 1.78, price-to-sales of 1140.27. Over the past 52 weeks the stock has ranged between $1.56 and $3.95, and currently trades 48.4% below its 52-week high.

On profitability, Sera Prognostics, Inc. generates a return on equity (ROE) of -46.71%, return on capital employed of -59.79%, an operating margin of -642.35%, a net profit margin of -563.86%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides